gene

CDKN1A

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CDKN1A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

473Connections
1Hypotheses
3Analyses
50Outgoing
50Incoming
0Experiments
11Debates

Summary

Cell cycle regulator with critical roles in neuronal survival, DNA damage response, and neurodegeneration

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolCDKN1A
Full NameCyclin-Dependent Kinase Inhibitor 1A
Chromosome6p21.31
Functionis a key cell cycle regulator that mediates p53-dependent cell cycle arrest.
Amino Acids164 aa
PathwaysTGF-β
UniProt IDP38936
NCBI Gene ID1026
Ensembl IDENSG00000100994
GeneCardsCDKN1A
Human Protein AtlasCDKN1A
N-terminal domainbinds and inhibits CDK2/cyclin E and CDK1/cyclin B complexes
C-terminal domaininteracts with PCNA (proliferating cell nuclear antigen), blocking DNA replication
p53-binding regioncontains p53-responsive elements for transcriptional activation
Neuronsparticularly in post-mitotic differentiated neurons
Associated DiseasesAging, Als, Alzheimer, Cancer, Cellular Senescence
Known Drugs/Compoundsrapamycin
InteractionsACTB, AGING, AGO2, AKT, AND, APOPTOSIS
SciDEX Hypothesesp21-Targeted Proteolysis-Targeting Chimeras (PROTA
KG Connections470 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: CDKN1A — AlphaFold P38936 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A

gene · 922 words

Pathway Diagram

graph TD
    CDKN1A["CDKN1A"] -->|"regulates"| Senescence["Senescence"]
    CDKN1A["CDKN1A"] -->|"regulates"| Ms["Ms"]
    CDKN1A["CDKN1A"] -->|"regulates"| Autism["Autism"]
    CDKN1A["CDKN1A"] -->|"associated"| Als["Als"]
    CDKN1A["CDKN1A"] -->|"associated"| Ms_1["Ms"]
    CDKN1A["CDKN1A"] -->|"therapeutic target"| Ms_2["Ms"]
    CYCS["CYCS"] -.->|"inhibits"| CDKN1A["CDKN1A"]
    CD4["CD4"] -->|"interacts"| CDKN1A["CDKN1A"]
    MAPK3["MAPK3"] -->|"interacts"| CDKN1A["CDKN1A"]
    ZAP70["ZAP70"] -->|"interacts"| CDKN1A["CDKN1A"]
    style CDKN1A fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (295)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:CDKN1Adata_indataset_row0.00
benchmark_ot_ad_answer_key:CDKN1Adata_indataset_row0.00
ds-83b31ef18d49provides_data_fordataset1.00
Senescent Cellsexpressed_incell_type0.95
SENESCENCEassociated_withgene0.90

Incoming (178)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:CDKN1Adata_indataset_row0.00
benchmark_ot_ad_answer_key:CDKN1Adata_indataset_row0.00
ds-83b31ef18d49data_indataset1.00
SQSTM1mediatesprotein0.95
Mir-302Btargetsbiomarker0.90

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
p21-Targeted Proteolysis-Targeting Chimeras (PROTACs) 0.000 - Senolytic therapy for age-related neurod

Mentioning Analyses (3)

Scientific analyses that reference this entity

Does pericyte senescence drive BBB breakdown or result from neurodegeneration as

neurodegeneration | 2026-04-25 | 6 hypotheses Top: 0.720

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.769

Senolytic therapy for age-related neurodegeneration

neurodegeneration | 2026-04-01 | 15 hypotheses Top: 0.822

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (11)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Hypothesis debate: SASP-Mediated Complement Cascade Amplification

closed · Rounds: 4 · Score: 0.40 · 2026-04-27

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Does pericyte senescence drive BBB breakdown or result from neurodegeneration as

closed · Rounds: 4 · Score: 0.68 · 2026-04-25

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

closed · Rounds: 4 · Score: 0.81 · 2026-04-23

Investigate the therapeutic potential of clearing senescent cells (senolytics) t

closed · Rounds: 4 · Score: 0.75 · 2026-04-16

Senolytics targeting p16/p21+ senescent astrocytes and microglia may reduce SASP

closed · Rounds: 4 · Score: 0.89 · 2026-04-06

Related Research

Hypotheses and analyses mentioning CDKN1A in their description or question text

No additional research found